Hugh Cole - Jun 2, 2023 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Hugh Cole
Stock symbol
ATXS
Transactions as of
Jun 2, 2023
Transactions value $
$0
Form type
4
Date filed
6/6/2023, 08:05 AM
Previous filing
Jan 11, 2023
Next filing
Jun 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (Right to Buy) Award $0 +14.1K $0.00 14.1K Jun 2, 2023 Common Stock 14.1K $11.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 2, 2023 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.